Department of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, USA
Department of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC, USA.
BMJ Open. 2022 Jul 7;12(7):e061691. doi: 10.1136/bmjopen-2022-061691.
Globally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic vulnerability and generates chronic stress. Anti-trans stigma occurs across multiple socioecological levels, resulting in multiple possible definitions and measurements of trans stigma. Understanding how trans stigma has been measured in low-income and middle-income countries (LMICs) is critical to health promotion efforts for trans communities. Accordingly, this scoping review will identify and examine how anti-trans stigma has been measured in existing LMIC-specific research to inform best practices for measurement of anti-trans stigma that includes consideration of local context.
This is the protocol for a scoping review of anti-trans stigma in LMICs. We will search (from January 2001 to December 2021) PubMed, WHO Global Medicus and EBSCO. Study selection will conform to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. Original studies in English, Spanish, Arabic or Russian will be included. Reviewers will independently screen all citations, full-text articles and abstract data. Data analysis will involve quantitative and qualitative methods. A narrative summary of findings will be conducted.
As a scoping review (no direct interaction with participants), this study is exempt from human subjects oversight. Understanding context-specific ways to measure anti-trans stigma is urgently needed to support trans health globally. The planned scoping review will help to address this gap. Results of the review will be disseminated in a peer-reviewed journal and likely in other media such as conferences, seminars and symposia. PROTOCOL REGISTRATION NUMBER: osf.io/qcs2v.
在全球范围内，跨性别者和其他性别多样化者（跨性别者）面临普遍的污名化，这导致了多个健康结果的健康不平等。污名是健康不平等的一个根本原因，因为它同时限制了资源的获取，导致了系统性脆弱，并产生了慢性压力。跨性别者的污名化存在于多个社会生态层次，导致了对跨性别者污名化的多种可能定义和衡量。了解跨性别者的污名化在低收入和中等收入国家（LMICs）中是如何被衡量的，对于促进跨性别者社区的健康努力至关重要。因此，本范围综述将确定并审查现有的特定于 LMIC 的研究中如何衡量反跨性别者污名化，以告知包括考虑当地背景在内的反跨性别者污名化衡量的最佳实践。
这是对 LMICs 中反跨性别者污名化进行范围综述的方案。我们将从 2001 年 1 月至 2021 年 12 月搜索 PubMed、世界卫生组织全球 Medicus 和 EBSCO。研究选择将符合系统评价和荟萃分析扩展的首选报告项目的范围综述清单。将包括英语、西班牙语、阿拉伯语或俄语的原始研究。审查员将独立筛选所有引用、全文文章和摘要数据。数据分析将涉及定量和定性方法。将进行发现的叙述性总结。
作为范围综述（不与参与者直接互动），本研究豁免人类受试者监督。迫切需要了解特定于上下文的反跨性别者污名化的衡量方法，以支持全球跨性别者的健康。计划中的范围综述将有助于解决这一差距。审查结果将在同行评议的期刊上发表，并可能在会议、研讨会和专题讨论会等其他媒体上发表。方案注册编号：osf.io/qcs2v。
